Interestingly, the addition of Sl-IFN to chemotherapy further reduced tumor size and improved mice survival similarly to what was observed in the groups treated with chemotherapy and IFNpti in both tumor models (Figure 3B,E,F). This evidence concerns the gene IFNA1 and neoplasm.